beta
STSA
Satsuma Pharmaceuticals Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
satsuma pharmaceuticals is focused on developing best-in-class products to address the unmet needs of migraine sufferers.
Market Cap: 36.5 Million
Primary Exchange: NASDAQ
Website: satsumarx.com
Shares Outstanding: 33.2 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.6496564056497673
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 179 trading days
From: 2020-06-22 To: 2023-06-07
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|